Tear Trough Filler Cost and Duration: Pricing, Longevity and Who Should Not Have It

Tear trough filler, usually called under eye filler, places a small amount of hyaluronic acid gel into the groove that runs from the inner corner of the eye outward along the bony orbital rim. The aim is to soften the shadow that groove casts, so the lower lid transitions smoothly into the cheek rather than dropping into a trench. It works on one specific finding: a genuine hollow, where volume has been lost along the rim or was never there. When the hollow is the problem, filling it well is a striking change, visible the same day.

What it does not do is brighten a tired looking under eye in general. Pigment, thin skin, protruding fat and loose skin all produce the same complaint in the mirror, and none improves because material was added along the bone. Being told plainly which one you have is the most valuable thing a consultation produces.

Two anatomical facts explain most of what follows. The skin of the lower lid is the thinnest on the body, so anything beneath it can show through, and the tissue underneath drains poorly and tolerates extra material badly.

Careful injectors turn away more people for tear trough filler than for almost any other common treatment, and the reason is diagnostic rather than merely cautious. The complaint is nearly always phrased the same way, but only one of its causes responds to volume. The table below sorts what people bring to an under eye consultation into what filler addresses, what it does not, and what does; the third column is the useful one.

Surgery deserves particular mention, because a large share of people asking about under eye filler are really describing lower lid fat prolapse, the bulge commonly called bags. Filling the hollow below a bulge can make the bulge read as larger rather than smaller, and a lower lid blepharoplasty is the oculoplastic or facial plastic surgery answer to it.

Dermal filler is priced by the syringe, and a syringe is a fixed volume of product, most commonly one milliliter. The under eye is one of the smallest volume areas on the face. Corrections here are measured in fractions of a milliliter per side, and more product does not produce a better result; past a modest point it reliably produces a worse one. Many patients are treated with well under a full syringe across both eyes.

Practices handle the remainder differently: some charge the full syringe rate whatever is used, some price the under eye as a named treatment area, and some hold the leftover for a follow up. Those produce very different totals from the same rate, so ask which applies before you agree.

The real price driver is the person injecting. Under eye work demands more anatomical knowledge, more restraint and more experience than most injectable areas, and injectors who do it well price accordingly. A rate noticeably below your local norm should read as a warning rather than a saving. Ask what the figure covers beyond product: the consultation, a follow up at around four weeks, and dissolving the filler with hyaluronidase if you dislike it.

Filler breaks down fastest in tissue that moves constantly, which is why lips are the shortest lived filler area. The under eye is the other extreme: product sits deep, against bone, under skin that barely moves, so it is broken down slowly.

Marketing commonly frames under eye filler as lasting about a year. Clinicians, and imaging of previously treated patients, have repeatedly found product still sitting in this area long after that, in some cases for years. There is no dependable number to quote you, and anyone offering a confident one is describing a product brochure rather than this part of the face.

In most areas, a result you dislike is a result you wait out. Here, waiting may not be a plan at all, which is reason to approach a first treatment conservatively. It also changes repeat treatment: topping the area up on an assumed annual schedule, without confirming the previous product has gone, is how people accumulate volume they never asked for and end up with a permanently heavy, puffy lower lid. If an injector proposes a routine refill without examining what is still there, ask how they know.

The most common disappointment here is not a lumpy result on day one. It is a result that looked good at the follow up and looked worse three weeks later. Hyaluronic acid attracts and holds water, and the lower lid is the least forgiving place on the face for that property, because it drains fluid away poorly. Product that settled beautifully can swell as it draws water in.

So judging this treatment early tells you very little. Ordinary swelling and bruising settle over the first week or two, but the water binding behavior of the gel keeps expressing itself for longer. A sensible injector underfills deliberately and reassesses at about four weeks.

The second failure mode specific to this area is the Tyndall effect. Filler placed too superficially beneath very thin skin scatters light and reads as a bluish gray cast under the lid. It is not a bruise and it does not fade, because nothing is resolving; it is the product visible through translucent skin. That is why experienced injectors place product deep, against the bone.

Both problems share a remedy, which is the reason to insist on a hyaluronic acid product here. Hyaluronidase dissolves filler, and an injector can use it to reduce an overfilled or discolored area rather than remove everything. That is the safety net, and also a cost to anticipate rather than assume.

Every filler injection carries a risk that product enters a blood vessel rather than settling beside it, obstructing it so the tissue it supplies is starved of blood. This is a vascular occlusion, and it is the complication that genuinely matters in aesthetic injecting.

What sets the under eye apart is where its vessels lead. The arteries here connect with the ophthalmic circulation, the network that supplies the eye, so filler forced under pressure into a vessel can travel against the flow and reach vessels feeding the skin or the retina itself. At one end of that range the consequence is skin necrosis, meaning death of the tissue. At the other, rarely, it is permanent loss of vision.

These outcomes are uncommon and they are documented in the medical literature. This page will not give you a figure for how often they happen, because published estimates rest on voluntary reporting and vary widely, and a precise sounding number would be false precision about the most serious thing here. Be skeptical of anyone who quotes an exact incidence rate. What is not in dispute is the ranking: the tear trough belongs with the nose and the area between the brows among the least forgiving sites on the face, well above the cheek, the chin and the jawline, for anatomical reasons rather than as a matter of opinion.

None of this argues against the treatment. It argues about who performs it and where. The risk falls sharply with an injector who knows the vascular anatomy in three dimensions, works slowly at low pressure with very small volumes, often prefers a blunt cannula to a sharp needle here, and practices somewhere prepared to respond the moment something looks wrong. Our guide to dermal filler safety and emergency hyaluronidase protocols sets out what that preparation looks like.

Start with experience in this specific area, because general injecting experience does not transfer to the under eye. Ask how long the injector has been treating tear troughs specifically, how often they do it, and ask to see their own before and after photographs rather than manufacturer marketing images. An injector who says the under eye is outside what they do, and refers you on, is showing exactly the judgment you want.

Then ask the two questions that matter most, directly. Is hyaluronidase in the building right now, unexpired and in the treatment room rather than sitting in a supplier order? And is there a written protocol for suspected vascular compromise, setting out who recognizes it, who treats it, and which ophthalmology or emergency service the practice escalates to? Ask too who performs the good faith exam that authorizes treatment and how you reach a clinician after hours, because a vascular complication is time critical.

Disclose everything: any filler placed anywhere in the face and when, previous eyelid or facial surgery, thyroid conditions, allergies, autoimmune disease and blood thinning medication. Fluid retention that already fluctuates is a strong argument against adding a water binding gel.

Finally, judge the quote on its structure rather than its size. A defensible one names the product by brand, states how much is planned and what happens to the remainder, gives a total, and spells out the follow up and the dissolving policy. Weigh the consultation too: an injector who tells you plainly that your problem is pigment, or skin, or fat, and that filler is the wrong tool, has given you something no price list contains.